rawfin.tv
X4 Pharmaceuticals Files Form 144 for Proposed Share Sale
RegulationstocksAI Generated

X4 Pharmaceuticals Files Form 144 for Proposed Share Sale

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

X4 Pharmaceuticals, Inc. submitted a Form 144 to the SEC, disclosing a proposed sale of 16,961 shares of common stock. This filing indicates an intent to sell restricted or control securities.

XFORSEC FilingInsider TradingBiotechnologyRegulation

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks